Multiple Sclerosis Treatments Market will Reach $11.9 Billion by 2011
Newswire Today (press release) - London,UK
A decision by the National Institute for Health and Clinical Excellence (NICE) to recommend Tysabri (natalizumab) for a severe form of multiple sclerosis ...
See all stories on this topic

Use of Tysabri for Crohn's questioned
Irish Times - Ireland
The multiple sclerosis drug Tysabri is no more effective against the bowel disorder Crohn's disease than other approved therapies, US drug reviewers said in ...
See all stories on this topic

Biogen Idec Swings to 2Q Profit
Forbes - NY,USA
A next-generation MS drug, Tysabri, posted sales of $72 million, of which Biogen will see $48 million from its drug development partnership with Ireland's ...
See all stories on this topic